IDBA / IDEX Biometrics ASA - ADR - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

IDEX Biometrics ASA - ADR
US ˙ NASDAQ
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

Grundläggande statistik
LEI 5967007LIEEXZXHECW11
CIK 1824036
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IDEX Biometrics ASA - ADR
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
August 10, 2023 EX-99.2

IDEX Biometrics ASA interim report for the first half of 2023

Exhibit 99.2 IDEX Biometrics ASA interim report for the first half of 2023 Oslo, Norway – 10 August 2023 - IDEX Biometrics ASA’s interim report for the first half of 2023 is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ Webcast A webcast presentation of the interim report will be held by

August 10, 2023 EX-99.1

IDEX Biometrics ASA Announces Effectiveness of Voluntary Delisting of ADSs from Nasdaq Stock Market

Exhibit 99.1 IDEX Biometrics ASA Announces Effectiveness of Voluntary Delisting of ADSs from Nasdaq Stock Market Oslo, Norway, August 10, 2023 – IDEX Biometrics ASA (“IDEX” or the “Company”) (Nasdaq: IDBA), a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control and digital identity, today announces that the Company’s voluntary delist

August 10, 2023 EX-99.1

August 9, 2023 The Board of Directors of IDEX Biometrics ASA

Interim Report Interim Report First half 2023 INTERIM REPORT FIRST half 2023 CEO’s commentS Dear Shareholders, IDEX Biometrics continues its positive momentum in the second quarter of 2023.

August 10, 2023 15F-12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15F CERTIFICATION OF A FOREIGN PRIVATE ISSUER’S TERMINATION OF REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMIN

15F-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15F CERTIFICATION OF A FOREIGN PRIVATE ISSUER’S TERMINATION OF REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMINATION OF THE DUTY TO FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39810

August 10, 2023 EX-99.3

Second Quarter 2023 Presentation IDEX Biometrics August 10, 2023

Second Quarter 2023 Presentation IDEX Biometrics August 10, 2023 Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ.

August 10, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2023 Commission File Number: 001-398

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office)

July 31, 2023 25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39810 IDEX Biometrics ASA T

25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39810 IDEX Biometrics ASA The Nasdaq Global Select Market (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

July 21, 2023 S-8 POS

As filed with the Securities and Exchange Commission on July 21, 2023

As filed with the Securities and Exchange Commission on July 21, 2023 Registration No.

July 21, 2023 EX-99.1

IDEX Biometrics announces intention to voluntary delist of American Depositary Shares from The Nasdaq Capital Market

Exhibit 99.1 IDEX Biometrics announces intention to voluntary delist of American Depositary Shares from The Nasdaq Capital Market Oslo, Norway, July 21, 2023 - IDEX Biometrics ASA (Nasdaq: IDBA) (“IDEX” or the “Company”), a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control and digital identity, today announced it has given formal

July 21, 2023 S-8 POS

As filed with the Securities and Exchange Commission on July 21, 2023

As filed with the Securities and Exchange Commission on July 21, 2023 Registration No.

July 21, 2023 POS AM

As filed with the Securities and Exchange Commission on July 21, 2023

POS AM As filed with the Securities and Exchange Commission on July 21, 2023 Registration No.

July 21, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2023 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) In

July 21, 2023 S-8 POS

As filed with the Securities and Exchange Commission on July 21, 2023

As filed with the Securities and Exchange Commission on July 21, 2023 Registration No.

July 21, 2023 S-8 POS

As filed with the Securities and Exchange Commission on July 21, 2023

As filed with the Securities and Exchange Commission on July 21, 2023 Registration No.

June 16, 2023 EX-99.1

Extraordinary general meeting in IDEX Biometrics held on 16 June 2023

Exhibit 99.1 Extraordinary general meeting in IDEX Biometrics held on 16 June 2023 IDEX Biometrics ASA held an extraordinary general meeting (EGM) on 16 June 2023. 361.9 million shares or 28% of the capital was represented at the meeting. The board withdrew agenda item 5 because there was no proposal from the nomination committee. All other resolutions were passed as proposed in the notice of the

June 16, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2023 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) In

June 15, 2023 S-8

As filed with the Securities and Exchange Commission on June 15, 2023

As filed with the Securities and Exchange Commission on June 15, 2023 Registration No.

June 15, 2023 EX-FILING FEES

Calculation of Filing Fee Table Form S-8 (Form Type) IDEX Biometrics ASA (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) IDEX Biometrics ASA (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Security Type Security Class Title(1) Fee Calculation Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Ordinary shares, nominal value NOK 0.

June 15, 2023 EX-4.1

ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 24 May 2023)

Exhibit 4.1 ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 24 May 2023) § 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. § 2 The objective of the Company is to deliver identification systems and other activities related to this. § 3 The business offices are in the Oslo municipality, Norway. § 4 The Company's sha

June 15, 2023 EX-99.1

Idex Biometrics ASA 2023 Subscription Rights Incentive Plan This 2023 Subscription Rights Incentive Plan (the “Plan”), effective as of 23 May 2023, as approved by the Annual General Meeting of the Company on 23 May 2023 in accordance with a proposal

Exhibit 99.1 Idex Biometrics ASA 2023 Subscription Rights Incentive Plan This 2023 Subscription Rights Incentive Plan (the “Plan”), effective as of 23 May 2023, as approved by the Annual General Meeting of the Company on 23 May 2023 in accordance with a proposal and resolution by the Board of Directors on 19 April 2023. 1. Purpose of the Plan. In accordance with the AGM Resolution, the Company has

June 15, 2023 EX-99.2

IDEX BIOMETRICS ASA 2023 EMPLOYEE SHARE PURCHASE PLAN (THE “PLAN”)

Exhibit 99.2 IDEX BIOMETRICS ASA 2023 EMPLOYEE SHARE PURCHASE PLAN (THE “PLAN”) The following constitute the provisions of the 2023 Employee Share Purchase Plan of IDEX Biometrics ASA (the “Company”), as approved by the Annual General Meeting of the Company on 23 May 2023 (the “Effective Date”) in accordance with a proposal and resolution by the Board of Directors on 19 April 2023. 1. Purpose The

May 30, 2023 EX-99.1

EX-99.1

NOTICE OF EXTRAORDINARY GENERAL MEETING IN IDEX BIOMETRICS ASA An Extraordinary General Meeting of IDEX Biometrics ASA ("the Company") will take place: 16 June 2023 at 10:00 hours CET At the date of the instant notice the Company’s resolved share capital amounts to NOK 192,880,861.

May 30, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

May 25, 2023 EX-99.6

IDEX Biometrics ASA - Contemplated Private Placement 24 May 2023

Exhibit 99.6 IDEX Biometrics ASA - Contemplated Private Placement 24 May 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREI

May 25, 2023 EX-99.5

EX-99.5

Copyright © 2023 IDEX Biometrics ASA. All Rights Reserved. | Copyright © 2023 IDEX Biometrics ASA. All Rights Reserved. IDEX Biometrics Q1 2023 Presentation May 23, 2023Copyright © 2023 IDEX Biometrics ASA. All Rights Reserved. | Copyright © 2023 IDEX Biometrics ASA. All Rights Reserved. | 2 Copyright © 2023 IDEX Biometrics ASA. All Rights Reserved. | Disclaimer This presentation includes forward-

May 25, 2023 EX-99.2

Grant of incentive subscription rights in IDEX Biometrics 22 May 2023

Exhibit 99.2 Grant of incentive subscription rights in IDEX Biometrics 22 May 2023 The board of directors of IDEX Biometrics ASA resolved on 22 May 2023, to issue 1,984,950 incentive subscription rights to new and existing employees and individual contractors of IDEX Biometrics. The grant was made under the Company's 2022 Subscription rights plan. The exercise price of 883,950 subscription rights

May 25, 2023 EX-99.4

IDEX Biometrics ASA interim report for the first quarter of 2023

Exhibit 99.4 IDEX Biometrics ASA interim report for the first quarter of 2023 Oslo, Norway – 23 May 2023 - IDEX Biometrics ASA’s interim report for the first quarter of 2023 is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Vince

May 25, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

May 25, 2023 EX-99.1

Annual general meeting in IDEX Biometrics held on 23 May 2023

Exhibit 99.1 Annual general meeting in IDEX Biometrics held on 23 May 2023 IDEX Biometrics ASA held its annual general meeting on 23 May 2023. 371.3 million shares or 32% of the capital was represented at the meeting. All resolutions were passed as proposed in the notice of the meeting. The following board was elected at the meeting: Larry Ciaccia, chair Board members: Deborah Davis, Annika Olsson

May 25, 2023 EX-99.7

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS

Exhibit 99.7 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. IDEX Biometrics ASA: Private placement of NOK 125 mi

May 25, 2023 EX-99.3

May 22, 2023 The Board of Directors of IDEX Biometrics ASA

Exhibit 99.3 First quarter 2023 INTERIM REPORT FIRST QUARTER 2023 CEO’s commentS May 22, 2023 Seven banks in Turkey and Bangladesh have in 2023 announced biometric payment card programs with IDEX. This is accelerating the trend from 2022 when the inflection point in the biometric payment card market was reached when banks launched nine new biometric payment card programs using IDEX Biometrics’ tec

May 3, 2023 EX-99

NOTICE OF ANNUAL GENERAL MEETING IN IDEX BIOMETRICS ASA

NOTICE OF ANNUAL GENERAL MEETING IN IDEX BIOMETRICS ASA The Annual General Meeting (the “AGM”) of IDEX Biometrics ASA (the "Company") will take place: Tuesday 23 May 2023 at 10:00 hours (CET) At the date of the instant notice the Company’s registered share capital amounts to NOK 175,346,238.

May 3, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

April 27, 2023 EX-99

IDEX Biometrics ASA 2022 Executive Remuneration Report IDEX Biometrics ASA 2022 Executive Remuneration Report

IDEX Biometrics ASA 2022 Executive Remuneration Report IDEX Biometrics ASA 2022 Executive Remuneration Report This report constitutes the Board of Directors of IDEX Biometrics ASA’s report to the 2023 annual general meeting about the implementation in 2022 of the Executive Remuneration Policy adopted by the 2022 annual general meeting.

April 27, 2023 EX-99

IDEX Biometrics ASA 2022 Annual report Statutory annual report in accordance with Norwegian requirements for IDEX Biometrics ASA for the year ended December 31, 2022.

IDEX Biometrics ASA 2022 Annual report Statutory annual report in accordance with Norwegian requirements for IDEX Biometrics ASA for the year ended December 31, 2022.

April 27, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2023 Commission File Number: 001-3981

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) I

April 26, 2023 EX-13

Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2022 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “E

April 26, 2023 EX-12

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Vincent Graziani, certify that: 1. I have reviewed this annual report on Form 20-F of IDEX Biometrics ASA; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to sta

April 26, 2023 EX-15

Consent of Ernst & Young AS, the registrant’s independent registered public accounting firm

Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statement (Form S-8 No. 333-254083) pertaining to the IDEX Biometrics ASA 2020 Subscription Rights Incentive Plan and the IDEX Biometrics ASA 2020 Employee Share Purchase Plan, of IDEX Biometrics ASA, (2) Registration Statemen

April 26, 2023 EX-2

Description of Share Capital and Articles of Association

Exhibit 2.4 DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Introduction Unless otherwise indicated or the context otherwise requires, all references in this exhibit to the terms “IDEX,” “IDEX Biometrics,” “IDEX Biometrics ASA,” “the Company,” “we,” “us” and “our” refer to IDEX Biometrics ASA, together with its subsidiaries. The following description of our share ca

April 26, 2023 EX-1

Amended and Restated Articles of Association of IDEX Biometrics ASA

Exhibit 1.1 ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 28 February 2023) § 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. § 2 The objective of the Company is to deliver identification systems and other activities related to this. § 3 The business offices are in the Oslo municipality, Norway. § 4 The Company'

April 26, 2023 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC

April 26, 2023 EX-13

Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2022 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “E

April 26, 2023 EX-12

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Eileen M. Wynne, certify that: 1. I have reviewed this annual report on Form 20-F of IDEX Biometrics ASA; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to stat

February 24, 2023 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2023 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2023 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office

February 24, 2023 EX-99

IDEX Biometrics ASA interim report for the fourth quarter and preliminary result for 2022

Exhibit 99.3 IDEX Biometrics ASA interim report for the fourth quarter and preliminary result for 2022 Oslo, Norway – 22 February 2023 - IDEX Biometrics ASA’s interim report for the fourth quarter and preliminary annual result for 2022 is attached to this notice (link below) The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A web

February 24, 2023 EX-99

Grant of incentive subscription rights in IDEX Biometrics 21 Feb 2023

Exhibit 99.1 Grant of incentive subscription rights in IDEX Biometrics 21 Feb 2023 The board of directors of IDEX Biometrics ASA resolved on 21 February 2023 to issue 1,423,800 incentive subscription rights to five new employees and individual contractors of IDEX Biometrics. The grant was made under the company's 2022 Subscription rights plan. The exercise price of the subscription rights is NOK 0

February 24, 2023 EX-99

February 21, 2023 The Board of Directors of IDEX Biometrics ASA

Exhibit 99.2 A INTERIM REPORT FOURTH QUARTER 2022 IDEX Biometrics IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity to create unmatched convenience and uncompromised security for users. Our solutions are based on patented and proprietary sensor technologies, integrated circuit designs

February 24, 2023 EX-99

IDEX Biometrics 4Q 2022 Presentation 22th February 2023 EX 99.4

IDEX Biometrics 4Q 2022 Presentation 22th February 2023 EX 99.4 Copyright © 2023 IDEX Biometrics ASA. All Rights Reserved. | Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations, estimates and projection

February 10, 2023 CORRESP

February 10, 2023

CORRESP 1 filename1.htm February 10, 2023 By Electronic Submission Mr. Robert S. Littlepage Mr. Joseph Cascarano Office of Technology Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: IDEX Biometrics ASA Form 20-F for the year ended December 31, 2021 Filed April 29, 2022 SEC File No. 001-39810 Dear Mr. Littlepage and Mr. Cascarano: Ple

February 2, 2023 CORRESP

IDEX Biometrics ASA Dronning Eufemias gate 16 NO-0191 Oslo, Norway

CORRESP 1 filename1.htm IDEX Biometrics ASA Dronning Eufemias gate 16 NO-0191 Oslo, Norway February 2, 2023 By Electronic Submission Mr. Robert S. Littlepage Mr. Joseph Cascarano Office of Technology Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: IDEX Biometrics ASA Form 20-F for the Fiscal Year Ended December 31, 2021 Filed April 2

January 19, 2023 CORRESP

IDEX Biometrics ASA Dronning Eufemias gate 16 NO-0191 Oslo, Norway

IDEX Biometrics ASA Dronning Eufemias gate 16 NO-0191 Oslo, Norway January 19, 2023 By Electronic Submission Mr.

December 13, 2022 EX-99.1

Extraordinary general meeting in IDEX Biometrics held on 9 December 2022

Exhibit 99.1 Extraordinary general meeting in IDEX Biometrics held on 9 December 2022 IDEX Biometrics ASA held an extraordinary general meeting on 9 December 2022. 376.8 million shares or 34% of the capital was represented at the meeting. All resolutions were passed as proposed in the notice of the meeting. The general meeting resolved to issue the Tranche 2 shares of the private placement disclos

December 13, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2022 Commission File Number: 001-3

6-K 1 d432267d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of p

November 23, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-3

6-K 1 d370313d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of p

November 23, 2022 EX-99.1

NOTICE OF EXTRAORDINARY GENERAL MEETING IDEX BIOMETRICS ASA

EX-99.1 2 d370313dex991.htm EX-99.1 Exhibit 99.1 NOTICE OF EXTRAORDINARY GENERAL MEETING IN IDEX BIOMETRICS ASA An Extraordinary General Meeting of IDEX Biometrics ASA (“the Company”) will take place: 9 December 2022 at 9:00 hours CET At the date of the instant notice the Company’s resolved share capital amounts to NOK 167,637,217.35 divided into 1,117,581,449 shares with par value per share of NO

November 18, 2022 EX-99.2

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS

Exhibit 99.2 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. IDEX Biometrics ASA: Private placement of USD 15m su

November 18, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office

November 18, 2022 EX-99.1

IDEX Biometrics ASA - Contemplated Private Placement

Exhibit 99.1 IDEX Biometrics ASA - Contemplated Private Placement NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 16 November 2022. IDEX Biometrics ASA (the ?Company?), a leading provider of advanced fingerp

November 14, 2022 EX-99.2

November 9, 2022 The Board of Directors of IDEX Biometrics ASA

EX-99.2 Exhibit 99.2 INTERIM REPORT THIRD QUARTER 2022 IDEX BIOMETRICS IDEX Biometrics ASA is a leading provider of biometric identification and authentication solutions, based on patented and proprietary fingerprint sensor technologies, integrated circuit designs, and software, targeting card-based applications for payments and digital authentication. We partner with leading card manufacturers an

November 14, 2022 EX-99.3

IDEX Biometrics Interim Report as of 30 September 2022

EX-99.3 4 d418073dex993.htm EX-99.3 Exhibit 99.3 IDEX Biometrics Interim Report as of 30 September 2022 Oslo, Norway – 10 November 2022 - IDEX Biometrics ASA’s interim report as of September 30, 2022 is enclosed with this notice. A webcast presentation will be held by Vince Graziani, Chief Executive Officer, today at 09:00 CET. The webcast presentation can be viewed at the following link: https://

November 14, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-3

6-K 1 d418073d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of p

November 14, 2022 EX-99.1

Grant of Incentive Subscription Rights in IDEX Biometrics 9 November 2022

EX-99.1 Exhibit 99.1 Grant of Incentive Subscription Rights in IDEX Biometrics 9 November 2022 The board of directors of IDEX Biometrics ASA resolved on 9 November 2022 to issue 2,470,000 incentive subscription rights to 15 new and continuing employees and individual contractors in the IDEX Biometrics group. The grant was made under the company’s 2022 incentive subscription rights plan as resolved

November 14, 2022 EX-99.4

Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations,

EX-99.4 Exhibit 99.4 IDEX Biometrics 3Q 2022 Presentation th 10 November 2022 Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations, estimates and projections about global economic conditions, the economi

September 8, 2022 CORRESP

IDEX Biometrics ASA Dronning Eufemias gate 16 NO-0191 Oslo, Norway

CORRESP 1 filename1.htm IDEX Biometrics ASA Dronning Eufemias gate 16 NO-0191 Oslo, Norway September 8, 2022 By Electronic Submission Mr. Robert S. Littlepage Mr. Joseph Cascarano Office of Technology Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: IDEX Biometrics ASA Form 20-F for the year ended December 31, 2021 Filed April 29, 202

August 15, 2022 424B4

60,000,000 Ordinary Shares Represented by 800,000 American Depositary Shares offered by Selling Shareholder

424B4 1 d369873d424b4.htm 424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-250186 PROSPECTUS 60,000,000 Ordinary Shares Represented by 800,000 American Depositary Shares offered by Selling Shareholder The selling shareholder identified in this prospectus may offer from time to time 60,000,000 ordinary shares of IDEX Biometrics ASA, represented by 800,000 American Depos

August 12, 2022 EX-99.4

Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations,

Enabling NextGen Smart Cards for Payments & Card-based Applications Quarterly Presentation for Q2 2022 August 2022 Oslo B?rs: IDEX Nasdaq: IDBA Copyright ? 2022 IDEX Biometrics ASA Exhibit 99.

August 12, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2022 Commission File Number: 001-398

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office)

August 12, 2022 EX-99.1

Grant of Incentive Subscription Rights in IDEX Biometrics 10 August 2022

Exhibit 99.1 Grant of Incentive Subscription Rights in IDEX Biometrics 10 August 2022 The board of directors of IDEX Biometrics ASA resolved on 10 August 2022 to issue 8,498,200 incentive subscription rights to 97 new and continuing employees and individual contractors in the IDEX Biometrics group. The grant was made under the company?s 2022 incentive subscription rights plan as resolved at the an

August 12, 2022 EX-99.2

August 10, 2022 The Board of Directors of IDEX Biometrics ASA

Exhibit 99.2 INTERIM REPORT FIRST HALF 2022 IDEX BIOMETRICS IDEX Biometrics ASA is a leading provider of biometric identification and authentication solutions, based on patented and proprietary fingerprint sensor technologies, integrated circuit designs, and software, targeting card-based applications for payments and digital authentication. We partner with leading card manufacturers and other ind

August 12, 2022 EX-99.3

IDEX Biometrics Interim Report for the First Half of 2022

Exhibit 99.3 IDEX Biometrics Interim Report for the First Half of 2022 Oslo, Norway ? 11 August 2022- IDEX Biometrics ASA?s interim report for the first half 2022, is enclosed with this notice. A webcast presentation will be held by Vince Graziani, Chief Executive Officer, at 13:00 CET. The webcast can be viewed at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/202208114

July 21, 2022 EX-FILING FEES

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Table Post-Effective Amendment No. 2 to Form F-1 on Form F-3 (Form Type) IDEX Biometrics ASA (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Fee Rate Amount o

July 21, 2022 POS AM

As filed with the Securities and Exchange Commission on July 21, 2022

Table of Contents As filed with the Securities and Exchange Commission on July 21, 2022 Registration No.

July 7, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2022 Commission File Number: 001-39810

6-K 1 d262460d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of princ

July 7, 2022 EX-99.1

Oslo, Norway – 06 July 2022 –

Exhibit 99.1 Oslo, Norway ? 06 July 2022 ? IDEX Biometrics ASA, today announced that Jamie Simms will step down from his position as Chief Financial Officer effective August 15, 2022. IDEX has initiated the process of finding his successor. The company has appointed Eileen Wynne, former Executive Vice President and Chief Accounting Officer at Analog Devices (NASDAQ: ADI), as interim CFO effective

June 8, 2022 EX-4.1

Amended and Restated Articles of Association of IDEX Biometrics ASA

Exhibit 4.1 ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 23 May 2022) ?1 The name of the company is IDEX Biometrics ASA and it is a public limited company. ?2 The objective of the Company is to deliver identification systems and other activities related to this. ?3 The business offices are in the Oslo municipality, Norway. ?4 The company?s shares

June 8, 2022 EX-99.2

IDEX Biometrics ASA 2022 Employee Share Purchase Plan

Exhibit 99.2 IDEX BIOMETRICS ASA 2022 EMPLOYEE SHARE PURCHASE PLAN (THE ?PLAN?) The following constitute the provisions of the 2022 Employee Share Purchase Plan of IDEX Biometrics ASA (the ?Company?), as approved by the Annual General Meeting of the Company on 12 May 2022 (the ?Effective Date?) in accordance with a proposal and resolution by the Board of Directors on 20 April 2022. 1. Purpose The

June 8, 2022 EX-FILING FEES

Filing Fee Table

EX-FILING FEES 7 d355040dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) IDEX Biometrics ASA (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Security Type Security Class Title(1) Fee Calculation Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Regi

June 8, 2022 S-8

As filed with the Securities and Exchange Commission on June 8, 2022

As filed with the Securities and Exchange Commission on June 8, 2022 Registration No.

June 8, 2022 EX-99.1

IDEX Biometrics ASA 2022 Subscription Rights Incentive Plan

Exhibit 99.1 IDEX BIOMETRICS ASA 2022 SUBSCRIPTION RIGHTS INCENTIVE PLAN This 2022 Subscription Rights Incentive Plan (the ?Plan?), effective as of 12 May 2022, was resolved by the board of directors of IDEX Biometrics ASA (the ?Company?) on 20 April 2022 and approved by the shareholders at the Company?s Annual General Meeting on 12 May 2022. 1. Purpose of the Plan. In accordance with the AGM Reso

May 17, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2022 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

May 17, 2022 EX-99.1

Mandatory notice of trade in IDEX 12 May 2022

Exhibit 99.1 Mandatory notice of trade in IDEX 12 May 2022 Vince Graziani, CEO and primary insider of IDEX Biometrics ASA, acquired the equivalent of 225,000 IDEX shares, ISIN NO0003070609, on 12 May 2022. Mr. Graziani purchased 3,000 IDBA, ISIN US45173W1053, the IDEX American Depositary Shares listed at the Nasdaq Capital Market in New York, in the market at USD 9.26 per IDBA. Each IDBA represent

May 16, 2022 EX-99.4

Enabling NextGen Smart Cards for Payments & Card-based Applications Quarterly Presentation for Q1 2022 May 2022 Oslo Børs: IDEX Nasdaq: IDBA Copyright © 2022 IDEX Biometrics ASA

Exhibit 99.4 Enabling NextGen Smart Cards for Payments & Card-based Applications Quarterly Presentation for Q1 2022 May 2022 Oslo B?rs: IDEX Nasdaq: IDBA Copyright ? 2022 IDEX Biometrics ASA Disclaimer This presentationincludes forward-looking informationandstatementsthataresubject torisksanduncertainties thatcouldcause actualresults to differ. Suchforward-looking informationand statements are bas

May 16, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2022 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

May 16, 2022 EX-99.3

IDEX Biometrics ASA Releases Interim Report for the First Quarter of 2022

Exhibit 99.3 IDEX Biometrics ASA Releases Interim Report for the First Quarter of 2022 Oslo, Norway ? 12 May 2022- IDEX Biometrics ASA, a leading provider of advanced fingerprint authentication solutions for payment cards and adjacent applications, today released financial results for the first quarter ending March 31, 2022. A webcast presentation will be held by Vince Graziani, Chief Executive Of

May 16, 2022 EX-99.1

Annual General Meeting in IDEX Biometrics Held on 12 May 2022

EX-99.1 2 d354353dex991.htm EX-99.1 Exhibit 99.1 Annual General Meeting in IDEX Biometrics Held on 12 May 2022 IDEX Biometrics ASA held its annual general meeting on 12 May 2022. 338.2 million shares or 33% of the capital was represented at the meeting. All resolutions were passed as proposed in the notice of the meeting. Following the annual general meeting, the board that was elected at the annu

May 16, 2022 EX-99.2

Note Regarding the COVID-19 Pandemic

Exhibit 99.2 ABOUT IDEX BIOMETRICS IDEX Biometrics ASA is a leading developer of fingerprint identification and authentication solutions, based on patented and proprietary sensor technologies, integrated circuit designs, and software, targeting battery-less, card-based applications. We also may license our technologies to third parties. Manufacturing is outsourced to large and established semicond

May 3, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2022 Commission File Number: 001-3981

6-K 1 d235321d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of prin

May 3, 2022 EX-99.2

IDEX Biometrics ASA 2021 Executive Remuneration Report

Exhibit 99.2 IDEX Biometrics ASA 2021 Executive Remuneration Report This report constitutes the Board of Directors of IDEX Biometrics ASA?s report to the 2022 annual general meeting about the implementation in 2021 of the Executive Remuneration Policy adopted by the 2021 annual general meeting. The report will be subject to an advisory vote at the 2022 annual general meeting. REMUNERATION POLICY T

May 3, 2022 EX-99.1

IDEX Biometrics ASA 2021 Annual report Statutory annual report in accordance with Norwegian requirements for IDEX Biometrics ASA for the year ended December 31, 2021.

Exhibit 99.1 IDEX Biometrics ASA 2021 Annual report Statutory annual report in accordance with Norwegian requirements for IDEX Biometrics ASA for the year ended December 31, 2021. This annual report is published to the company?s shareholders and the general public as well as the European Regulatory Network which includes the Oslo B?rs. The document is filed with the Norwegian Register of company a

April 29, 2022 EX-2.4

Description of Share Capital and Articles of Association

Exhibit 2.4 DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Introduction Unless otherwise indicated or the context otherwise requires, all references in this exhibit to the terms ?IDEX,? ?IDEX Biometrics,? ?IDEX Biometrics ASA,? ?the Company,? ?we,? ?us? and ?our? refer to IDEX Biometrics ASA, together with its subsidiaries. The following description of our share ca

April 29, 2022 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

EX-12.1 Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Vincent Graziani, certify that: 1. I have reviewed this annual report on Form 20-F of IDEX Biometrics ASA; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi

April 29, 2022 EX-2.5

Description of American Depositary Shares

Exhibit 2.5 DESCRIPTION OF AMERICAN DEPOSITARY SHARES OF IDEX BIOMETRICS ASA Introduction Unless otherwise indicated or the context otherwise requires, all references in this exhibit to the terms ?IDEX,? ?IDEX Biometrics,? ?IDEX Biometrics ASA,? ?the Company,? ?we,? ?us? and ?our? refer to IDEX Biometrics ASA together with its subsidiaries. The following description of our American Depositary Shar

April 29, 2022 EX-13.1

Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

EX-13.1 Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2021 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934

April 29, 2022 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

EX-12.2 Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, James A. Simms, certify that: 1. I have reviewed this annual report on Form 20-F of IDEX Biometrics ASA; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit

April 29, 2022 EX-1.1

Amended and Restated Articles of Association of IDEX Biometrics ASA

Exhibit 1.1 ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 4 March 2022) ? 1 The name of the Company is IDEX Biometrics ASA and it is a public limited company. ? 2 The objective of the Company is to deliver identification systems and other activities related to this. ? 3 The business offices are in the Oslo municipality, Norway. ? 4 The Company?s sh

April 29, 2022 EX-13.2

Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

EX-13.2 Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2021 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934

April 29, 2022 20-F

Form 20-F

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

April 29, 2022 EX-15.1

Consent of Ernst & Young AS, the registrant’s independent registered public accounting firm

Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statement (Form S-8 No. 333-254083) pertaining to the IDEX Biometrics ASA 2020 Subscription Rights Incentive Plan and the IDEX Biometrics ASA 2020 Employee Share Purchase Plan, of IDEX Biometrics ASA, and (2) Registration Stat

April 22, 2022 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2022 Commission File Number: 001-3981

6-K 1 d142470d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of prin

April 22, 2022 EX-99.1

NOTICE OF ANNUAL GENERAL MEETING IN IDEX BIOMETRICS ASA

EX-99.1 2 d142470dex991.htm EX-99.1 Exhibit 99.1 NOTICE OF ANNUAL GENERAL MEETING IN IDEX BIOMETRICS ASA The Annual General Meeting (the “AGM”) of IDEX Biometrics ASA (the “Company”) will take place: Wednesday 12 May 2022 at 14.00 hours (CET) at Advokatfirmaet Ræder, Dronning Eufemias gate 11 in Oslo, Norway At the date of the instant notice the Company’s registered share capital amounts to NOK 15

February 25, 2022 EX-99.4

Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations,

Exhibit 99.4 Enabling NextGen Smart Cards for Payments & Card-based Applications February 2022 Oslo B?rs: IDEX Nasdaq: IDBA Copyright ? 2022 IDEX Biometrics ASA Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current ex

February 25, 2022 EX-99.3

IDEX Biometrics ASA Releases Interim Report for the Fourth Quarter of 2021

EX-99.3 4 d286565dex993.htm EX-99.3 Exhibit 99.3 IDEX Biometrics ASA Releases Interim Report for the Fourth Quarter of 2021 Oslo, Norway – 24 February 20212- IDEX Biometrics ASA (the Company), a leading provider of advanced fingerprint authentication solutions for payment cards and adjacent applications, today released financial results for the fourth quarter ending December 31, 2021, and, on a pr

February 25, 2022 EX-99.2

Note Regarding the COVID-19 Pandemic

Exhibit 99.2 INTERIM REPORT FOR FOURTH QUARTER AND PRELIMINARY RESULT 2021 INTERIM REPORT FOURTH QUARTER 2021 ABOUT IDEX BIOMETRICS IDEX Biometrics ASA is a leading developer of fingerprint identification and authentication solutions, based on patented and proprietary sensor technologies, integrated circuit designs, and software, targeting battery-less, card-based applications. We also may license

February 25, 2022 6-K

Form 6-K

6-K 1 d286565d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of February 2022 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of p

February 25, 2022 EX-99.1

Grant of Incentive Subscription Rights in IDEX Biometrics 23 February 2022

Exhibit 99.1 Grant of Incentive Subscription Rights in IDEX Biometrics 23 February 2022 The board of directors of IDEX Biometrics ASA resolved on 23 February 2022 to issue 8,350,900 incentive subscription rights to 30 new and continuing employees and individual contractors in the IDEX Biometrics group. The grant was made under the company?s 2021 incentive subscription rights plan as resolved at th

November 12, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2021 Commission File Number: 001-3

6-K 1 d17782d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of pr

November 12, 2021 EX-99.1

IDEX Biometrics ASA—Contemplated Private Placement

EX-99.1 2 d17782dex991.htm EX-99.1 Exhibit 99.1 IDEX Biometrics ASA—Contemplated Private Placement NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 9 November 2021. IDEX Biometrics ASA (the “Company”), a lead

November 12, 2021 EX-99.2

Published header:

Exhibit 99.2 Published header: IDEX Biometrics ASA: Private placement successfully completed on 9 November 2021 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. IDEX Biometrics ASA: Private placement successfully c

November 12, 2021 EX-99.3

Mandatory notice of trade in IDEX 9 November 2021

EX-99.3 4 d17782dex993.htm EX-99.3 Exhibit 99.3 Mandatory notice of trade in IDEX 9 November 2021 Reference is made to IDEX Biometrics ASA’s private placement on 9 November 2021 of 89,777,824 shares at NOK 2.85 per share. Allocation has been communicated to investors today, IDEX discloses transactions by the following primary insiders in IDEX shares, ISIN NO0003070609: Primary insiders were alloca

November 8, 2021 EX-99.2

IDEX Biometrics Interim Report for the Third Quarter of 2021

Exhibit 99.2 IDEX Biometrics Interim Report for the Third Quarter of 2021 Oslo, Norway – 04 November 2021—IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions for payment cards and adjacent applications, today released its financial results for the three and nine months ended September 30, 2021. A webcast presentation will be held by Vince Gra

November 8, 2021 EX-99.1

Note Regarding the COVID-19 Pandemic

EX-99.1 2 d254283dex991.htm EX-99.1 Exhibit 99.1 FINANCIAL REVIEW THIRD QUARTER 2021 ABOUT IDEX BIOMETRICS IDEX Biometrics ASA is a leading developer of fingerprint identification and authentication solutions, based on patented and proprietary sensor technologies, integrated circuit designs, and software, targeting battery-less, card-based applications. We also may license our technologies to thir

November 8, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2021 Commission File Number: 001-3

6-K 1 d254283d6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of p

November 8, 2021 EX-99.3

Enabling NextGen Smart Cards for Payments & Card-based Applications November 2021 Oslo Børs: IDEX Nasdaq: IDBA Copyright © 2021 IDEX Biometrics

Exhibit 99.3 Enabling NextGen Smart Cards for Payments & Card-based Applications November 2021 Oslo B?rs: IDEX Nasdaq: IDBA Copyright ? 2021 IDEX Biometrics Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expect

August 31, 2021 EX-4.1

Amended and Restated Articles of Association of IDEX Biometrics ASA

EX-4.1 2 d145456dex41.htm EX-4.1 Exhibit 4.1 ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 20 August 2021) § 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. § 2 The objective of the Company is to deliver identification systems and other activities related to this. § 3 The business offices are in the Oslo municip

August 31, 2021 EX-99.2

IDEX Biometrics ASA 2021 Employee Share Purchase Plan

EX-99.2 6 d145456dex992.htm EX-99.2 Exhibit 99.2 IDEX BIOMETRICS ASA 2021 EMPLOYEE SHARE PURCHASE PLAN (THE “PLAN”) The following constitute the provisions of the 2021 Employee Share Purchase Plan of IDEX Biometrics ASA (the “Company”), as approved by the Annual General Meeting of the Company on 12 May 2021 (the “Effective Date”) in accordance with a proposal and resolution by the Board of Directo

August 31, 2021 EX-99.1

IDEX Biometrics ASA 2021 Subscription Rights Incentive Plan

EX-99.1 5 d145456dex991.htm EX-99.1 Exhibit 99.1 IDEX BIOMETRICS ASA 2021 SUBSCRIPTION RIGHTS INCENTIVE PLAN This 2021 Subscription Rights Incentive Plan (the “Plan”), effective as of 12 May 2021, was resolved by the board of directors of IDEX Biometrics ASA (the “Company”) on [*] 2021 in accordance with a resolution by the Company’s annual general meeting on 12 May 2021. 1. Purpose of the Plan. I

August 31, 2021 S-8

As filed with the Securities and Exchange Commission on August 31, 2021

As filed with the Securities and Exchange Commission on August 31, 2021 Registration No.

August 13, 2021 EX-99.3

IDEX Biometrics ASA releases Interim Report for the First Half of 2021

EX-99.3 4 d204804dex993.htm EX-99.3 Exhibit 99.3 IDEX Biometrics ASA releases Interim Report for the First Half of 2021 Oslo, Norway – 12 August 2021 - IDEX Biometrics ASA (IDEX Biometrics or the Company), a leading provider of advanced fingerprint identification and authentication solutions for payment cards and adjacent applications, today released its financial results for the three and six mon

August 13, 2021 EX-99.4

Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations,

EX-99.4 5 d204804dex994.htm EX-99.4 Exhibit 99.4 Interim Report for First Half 2021 12 August 2021Exhibit 99.4 Interim Report for First Half 2021 12 August 2021 Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current ex

August 13, 2021 EX-99.2

August 11, 2021 The Board of Directors of IDEX Biometrics ASA

EX-99.2 3 d204804dex992.htm EX-99.2 Exhibit 99.2 IDEX INTERIM REPORT FOR FIRST HALF 2021 REVIEW FIRST HALF 2021 CEO’S COMMENTS August 11, 2021 Our financial results for the second quarter were in line with our first quarter results, largely reflecting sustained shipments to our existing access control customer, complemented by initial shipments of fingerprint authentication solutions for payment c

August 13, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2021 Commission File Number: 001-398

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office)

August 13, 2021 EX-99.1

Grant of Incentive Subscription Rights in IDEX Biometrics 11 August 2021

EX-99.1 2 d204804dex991.htm EX-99.1 Exhibit 99.1 Grant of Incentive Subscription Rights in IDEX Biometrics 11 August 2021 The board of directors of IDEX Biometrics ASA resolved on 11 August 2021 to issue 8,880,100 incentive subscription rights to 103 new and continuing employees and individual contractors in the IDEX Biometrics group. The grant was made under the company’s 2021 incentive subscript

June 9, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2021 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant’s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) In

June 9, 2021 EX-99.2

Grant of Incentive Subscription Rights in IDEX Biometrics 3 June 2021

Exhibit 99.2 Grant of Incentive Subscription Rights in IDEX Biometrics 3 June 2021 The board of directors of IDEX Biometrics ASA resolved on 3 June 2021 to issue 2,000,000 incentive subscription rights to an officer in the IDEX group. The grant was made under the company?s 2021 incentive subscription rights plan as resolved at the annual general meeting on 12 May 2021. The exercise price of the su

June 9, 2021 EX-99.1

IDEX Biometrics: Employee Share Purchase Plan – 3 June 2021

Exhibit 99.1 IDEX Biometrics: Employee Share Purchase Plan ? 3 June 2021 The board of directors of IDEX Biometrics ASA has resolved to issue 972,642 ordinary shares at NOK 2.08 per share to employees who participate in the company?s Employee Share Purchase Plan (ESPP), which plan was approved by the annual general meeting on 15 May 2020. 54 employees participated in the ESPP in this period. The pa

June 8, 2021 424B4

60,000,000 Ordinary Shares Represented by 800,000 American Depositary Shares

Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-250186 PROSPECTUS 60,000,000 Ordinary Shares Represented by 800,000 American Depositary Shares Our American Depositary Shares, or ADSs, each representing 75 ordinary shares of IDEX Biometrics ASA, are listed on the Nasdaq Capital Market, or Nasdaq, under the symbol “IDBA”. The ADSs began trading on March 1, 2021. The closing p

June 3, 2021 POS AM

As filed with the Securities and Exchange Commission on June 2, 2021.

Table of Contents As filed with the Securities and Exchange Commission on June 2, 2021.

May 13, 2021 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2021 Commission File Number: 001-39810

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

May 13, 2021 EX-99.5

First Quarter 2021 Presentation

Exhibit 99.5 First Quarter 2021 Presentation IDEX May 12, 2021 Disclaimer This presentation includes forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations, estimates and projections about global economic conditions, the economic conditions of

May 13, 2021 EX-99.1

IDEX Biometrics Appoints Catharina Eklof as Chief Commercial Officer

Exhibit 99.1 IDEX Biometrics Appoints Catharina Eklof as Chief Commercial Officer Oslo, Norway – 12 May 2021 - IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions, has appointed Catharina Eklof as Chief Commercial Officer (CCO), effective June 1, 2021. Catharina Eklof brings 20 years of global executive management across Financial Services, R

May 13, 2021 EX-99.3

IDEX INTERIM REPORT FIRST QUARTER 2021

EX-99.3 4 d508403dex993.htm EX-99.3 Exhibit 99.3 IDEX INTERIM REPORT FIRST QUARTER 2021 INTERIM REPORT FIRST QUARTER 2021 CEO’S COMMENTS In 2018, IDEX embarked on a new, focused strategy to reposition the company as the leading provider of fingerprint biometric solutions for payment cards and adjacent market applications. The demanding technical challenges of these applications required new, highl

May 13, 2021 EX-99.4

IDEX Biometrics ASA releases Interim Report for the First Quarter of 2021

EX-99.4 5 d508403dex994.htm EX-99.4 Exhibit 99.4 IDEX Biometrics ASA releases Interim Report for the First Quarter of 2021 Oslo, Norway – 12 May 2021 - IDEX Biometrics ASA (IDEX or the Company), a leading provider of advanced fingerprint identification and authentication solutions for payment cards and adjacent applications, today released its financial results for the first quarter ended March 31

May 13, 2021 EX-99.2

Annual General Meeting in IDEX Biometrics Held on 12 May 2021

EX-99.2 3 d508403dex992.htm EX-99.2 Exhibit 99.2 Annual General Meeting in IDEX Biometrics Held on 12 May 2021 IDEX Biometrics ASA held its annual general meeting on 12 May 2021. 390.6 million shares or 43% of the capital was represented at the meeting. All other resolutions were made as proposed in the notice of the meeting. Following the annual general meeting, the board consists of: Morten Opst

May 7, 2021 6-K

Current Report of Foreign Issuer - 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) Ind

May 7, 2021 EX-99.1

Senior Financial Services Executive Annika Olsson Nominated to IDEX Biometrics’ Board

EX-99.1 2 d431645dex991.htm EX-99.1 Exhibit 99.1 Senior Financial Services Executive Annika Olsson Nominated to IDEX Biometrics’ Board Oslo, Norway – 4 May 2021—IDEX Biometrics ASA, is a leading provider of advanced fingerprint identification and authentication solutions. The nomination committee proposes to the annual general meeting on 12 May 2021 that Annika Olsson is elected to the company’s b

April 23, 2021 EX-2.5

Description of American Depositary Shares

EX-2.5 Exhibit 2.5 DESCRIPTION OF AMERICAN DEPOSITARY SHARES OF IDEX BIOMETRICS ASA Introduction Unless otherwise indicated or the context otherwise requires, all references in this exhibit to the terms “IDEX,” “IDEX Biometrics,” “IDEX Biometrics ASA,” “the Company,” “we,” “us” and “our” refer to IDEX Biometrics ASA together with its subsidiaries. The following description of our American Deposita

April 23, 2021 EX-12.2

Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

EX-12.2 Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Derek D’Antilio, certify that: 1. I have reviewed this annual report on Form 20-F of IDEX Biometrics ASA; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit

April 23, 2021 EX-12.1

Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

EX-12.1 Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Vincent Graziani, certify that: 1. I have reviewed this annual report on Form 20-F of IDEX Biometrics ASA; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi

April 23, 2021 EX-13.2

Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

EX-13.2 Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2020 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934

April 23, 2021 EX-1.1

Amended and Restated Articles of Association of IDEX Biometrics ASA

EX-1.1 Exhibit 1.1 ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 9 March 2021) § 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. § 2 The objective of the Company is to deliver identification systems and other activities related to this. § 3 The business offices are in the Oslo municipality, Norway. § 4 The compa

April 23, 2021 EX-13.1

Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

EX-13.1 Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The certification set forth below is being submitted in connection with the Annual Report on Form 20-F for the year ended December 31, 2020 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934

April 23, 2021 EX-15.1

Consent of Ernst & Young AS, the registrant’s independent registered public accounting firm

Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statement (Form F-1 No. 333-250186) of IDEX Biometrics ASA, and (2) Registration Statement (Form S-8 No. 333-254083) pertaining to the IDEX Biometrics ASA 2020 Subscription Rights Incentive Plan and the IDEX Biometrics ASA 202

April 23, 2021 20-F

Form 20-F

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

April 23, 2021 EX-2.4

Description of Share Capital and Articles of Association

EX-2.4 Exhibit 2.4 DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Introduction Unless otherwise indicated or the context otherwise requires, all references in this exhibit to the terms “IDEX,” “IDEX Biometrics,” “IDEX Biometrics ASA,” “the Company,” “we,” “us” and “our” refer to IDEX Biometrics ASA together with its subsidiaries. The following description of our sh

April 22, 2021 EX-99.2

IDEX Biometrics ASA 2020 Annual report This report constitutes the statutory annual report in accordance with Norwegian requirements for IDEX Biometrics ASA for the year ended December 31, 2020.

Exhibit 99.2 IDEX Biometrics ASA 2020 Annual report This report constitutes the statutory annual report in accordance with Norwegian requirements for IDEX Biometrics ASA for the year ended December 31, 2020. About this document This document is published to the company?s shareholders and the general public as well as the European Regulatory Network which includes the Oslo B?rs. The document is fil

April 22, 2021 6-K

Current Report of Foreign Issuer - 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) I

April 22, 2021 EX-99.1

IDEX Biometrics Appoints James Simms as Chief Financial Officer

Exhibit 99.1 IDEX Biometrics Appoints James Simms as Chief Financial Officer Oslo, Norway ? 21 April 2021 - IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions, has appointed James A. Simms as Chief Financial Officer with effect from 26 April 2021. Mr. Simms is an accomplished executive, with extensive experience with publicly-listed companie

April 22, 2021 EX-99.3

NOTICE OF ANNUAL GENERAL MEETING IN IDEX BIOMETRICS ASA

Exhibit 99.3 NOTICE OF ANNUAL GENERAL MEETING IN IDEX BIOMETRICS ASA The Annual General Meeting of IDEX Biometrics ASA (?the Company?) will take place: Wednesday 12 May 2021 at 12.00 hours (CET) At the date of the instant notice the Company?s registered share capital amounts to NOK 137,508,072.75 divided into 916,720,485 shares with par value per share of NOK 0.15. Each share gives right to one vo

April 1, 2021 6-K

Current Report of Foreign Issuer - 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of March 2021 Commission File Number: 001-39810 IDEX Biometrics ASA (Translation of registrant?s name into English) Dronning Eufemias gate 16 Oslo, Norway (Address of principal executive office) I

April 1, 2021 EX-99.1

IDEX Biometrics - CFO

EX-99.1 2 d890993dex991.htm EX-99.1 Exhibit 99.1 IDEX Biometrics - CFO Oslo, Norway – 31 March 2021 - IDEX Biometrics ASA, today announced that Derek P. D’Antilio will step down from his position as Chief Financial Officer effective 23 April 2021. Mr. D’Antilio has accepted a position with another company. IDEX has initiated the process of finding his successor and expects to appoint the Company’s

March 10, 2021 S-8

- S-8

As filed with the Securities and Exchange Commission on March 10, 2021 Registration No.

March 1, 2021 424B4

60,000,000 Ordinary Shares Represented by 800,000 American Depositary Shares

Table of Contents Filed Pursuant to 424(b)(4) Registration Statement No. 333-250186 PROSPECTUS 60,000,000 Ordinary Shares Represented by 800,000 American Depositary Shares Our American Depositary Shares, or ADSs, each representing 75 ordinary shares of IDEX Biometrics ASA, have been approved for listing on the Nasdaq Capital Market, or Nasdaq, under the symbol ?IDBA?. The ADSs are expected to begi

February 25, 2021 CORRESP

-

Joshua A. Kaufman T: +1 212 479 6495 [email protected] Via EDGAR February 25, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Joseph Cascarano Mr. Robert Littlepage Mr. Mitchell Austin Mr. Larry Spirgel Re: IDEX Biometrics ASA Amendment No. 2 to Registration Statement on Form F-1 Filed February 19, 2021 File No.

February 25, 2021 F-1/A

- F-1/A

Table of Contents As filed with the Securities and Exchange Commission on February 25, 2021.

February 25, 2021 EX-3.1

Amended and Restated Articles of Association of IDEX Biometrics ASA

Exhibit 3.1 English version, office translation for information purposes: ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 15 February 2021) ? 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. ? 2 The objective of the Company is to deliver identification systems and other activities related to this. ? 3 The business

February 25, 2021 CORRESP

-

IDEX BIOMETRICS ASA Dronning Eufemias gate 16 NO-0191 Oslo Norway February 25, 2021 VIA EDGAR U.

February 19, 2021 F-1/A

- F-1/A

Table of Contents As filed with the Securities and Exchange Commission on February 19, 2021.

December 15, 2020 8-A12B

Form 8-A

8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 IDEX Biometrics ASA (Exact name of registrant as specified in its charter) Kingdom of Norway Not applicable (State or other jurisdiction of incorporation or organization) (I.

December 4, 2020 F-1/A

- F-1/A

F-1/A Table of Contents As filed with the Securities and Exchange Commission on December 4, 2020.

December 4, 2020 CORRESP

-

Joshua A. Kaufman T: +1 212 479 6495 [email protected] Via EDGAR December 4, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Joseph Cascarano Mr. Robert Littlepage Mr. Mitchell Austin Mr. Larry Spirgel Re: IDEX Biometrics ASA Registration Statement on Form F-1 Filed November 19, 2020 File No. 333-250186 Ladies a

November 19, 2020 EX-10.2

IDEX Biometrics ASA 2020 Employee Share Purchase Plan

EX-10.2 Exhibit 10.2 IDEX BIOMETRICS ASA 2020 EMPLOYEE SHARE PURCHASE PLAN (THE “PLAN”) The following constitute the provisions of the 2020 Employee Share Purchase Plan of IDEX Biometrics ASA (the “Company”), as approved by the Annual General Meeting of the Company on 15 May 2020 (the “Effective Date”) in accordance with a proposal and resolution by the Board of Directors on 23 April 2020. 1. Purp

November 19, 2020 EX-3.1

Amended and Restated Articles of Association of IDEX Biometrics ASA

EX-3.1 Exhibit 3.1 English version, office translation for information purposes: ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 1 July 2020) § 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. § 2 The objective of the Company is to deliver identification systems and other activities related to this. § 3 The busines

November 19, 2020 EX-10.1

IDEX Biometrics ASA 2020 Subscription Rights Incentive Plan

Exhibit 10.1 IDEX BIOMETRICS ASA 2020 SUBSCRIPTION RIGHTS INCENTIVE PLAN This 2020 Subscription Rights Incentive Plan (the “Plan”), effective as of 15 May 2020, was resolved by the board of directors of IDEX Biometrics ASA (the “Company”) on 23 July 2020 in accordance with a resolution by the Company’s annual general meeting on 15 May 2020. 1. Purpose of the Plan. In accordance with the AGM Resolu

November 19, 2020 EX-10.5

Form of Indemnity Agreement between the registrant and its executive officers and directors

EX-10.5 Exhibit 10.5 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of [ ] 2020 between IDEX Biometrics ASA, a Norwegian public limited liability company (the “Company”), and [ ] (“Indemnitee”). RECITALS: WHEREAS, highly competent persons may be reluctant to serve corporations as directors or officers unless they are provided with adequate p

November 19, 2020 EX-21.1

Subsidiaries of IDEX Biometrics ASA

EX-21.1 9 d27069dex211.htm EX-21.1 Exhibit 21.1 Subsidiaries of IDEX Biometrics ASA Name of Subsidiary Jurisdiction of Organization IDEX Holding Company Inc. Delaware, USA IDEX America Inc. Delaware, USA IDEX Biometrics UK Ltd. United Kingdom IDEX Electronics (Shanghai) Co., Ltd. China

November 19, 2020 EX-10.3

Supply Agreement, by and between IDEX Biometrics ASA and IDEMIA France SAS, dated as of February 13, 2020

EX-10.3 Exhibit 10.3 Certain information in this document, marked by brackets and asterisks, has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed. Supply Agreement EXECUTION VERSION Certain information in this document

November 19, 2020 F-1

Form F-1

F-1 Table of Contents As filed with the Securities and Exchange Commission on November 18, 2020.

November 19, 2020 EX-10.4

Master Services Agreement, by and between IDEX Biometrics ASA and Bloomberg L.P., dated as of April 4, 2019

EX-10.4 Exhibit 10.4 Certain information in this document, marked by brackets and asterisks, has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed. MASTER SERVICES AGREEMENT This Master Services Agreement (this “Agreeme

November 18, 2020 CORRESP

-

Joshua A. Kaufman T: +1 212 479 6495 [email protected] Via EDGAR November 18, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Joseph Cascarano Mr. Robert Littlepage Mr. Mitchell Austin Mr. Larry Spirgel Re: IDEX Biometrics ASA Draft Registration Statement on Form F-1 Submitted October 14, 2020 CIK No. 0001824036

October 14, 2020 DRS

As confidentially submitted to the Securities and Exchange Commission on October 14, 2020. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confident

Table of Contents As confidentially submitted to the Securities and Exchange Commission on October 14, 2020.

October 14, 2020 EX-10.2

IDEX BIOMETRICS ASA 2020 EMPLOYEE SHARE PURCHASE PLAN (THE ?PLAN?)

EX-10.2 Exhibit 10.2 IDEX BIOMETRICS ASA 2020 EMPLOYEE SHARE PURCHASE PLAN (THE “PLAN”) The following constitute the provisions of the 2020 Employee Share Purchase Plan of IDEX Biometrics ASA (the “Company”), as approved by the Annual General Meeting of the Company on 15 May 2020 (the “Effective Date”) in accordance with a proposal and resolution by the Board of Directors on 23 April 2020. 1. Purp

October 14, 2020 EX-3.1

English version, office translation for information purposes: ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 1 July 2020)

Exhibit 3.1 English version, office translation for information purposes: ARTICLES OF ASSOCIATION OF IDEX BIOMETRICS ASA Corp. ID no. NO 976 846 923 VAT (last amended on 1 July 2020) ? 1 The name of the company is IDEX Biometrics ASA and it is a public limited company. ? 2 The objective of the Company is to deliver identification systems and other activities related to this. ? 3 The business offic

October 14, 2020 EX-10.1

IDEX BIOMETRICS ASA 2020 SUBSCRIPTION RIGHTS INCENTIVE PLAN This 2020 Subscription Rights Incentive Plan (the ?Plan?), effective as of 15 May 2020, was resolved by the board of directors of IDEX Biometrics ASA (the ?Company?) on 23 July 2020 in accor

Exhibit 10.1 IDEX BIOMETRICS ASA 2020 SUBSCRIPTION RIGHTS INCENTIVE PLAN This 2020 Subscription Rights Incentive Plan (the ?Plan?), effective as of 15 May 2020, was resolved by the board of directors of IDEX Biometrics ASA (the ?Company?) on 23 July 2020 in accordance with a resolution by the Company?s annual general meeting on 15 May 2020. 1. Purpose of the Plan. In accordance with the AGM Resolu

October 14, 2020 EX-21.1

Subsidiaries of IDEX Biometrics ASA Name of Subsidiary Jurisdiction of Organization IDEX Holding Company Inc. Delaware, USA IDEX America Inc. Delaware, USA IDEX Biometrics UK Ltd. United Kingdom IDEX Electronics (Shanghai) Co., Ltd. China

EX-21.1 6 filename6.htm Exhibit 21.1 Subsidiaries of IDEX Biometrics ASA Name of Subsidiary Jurisdiction of Organization IDEX Holding Company Inc. Delaware, USA IDEX America Inc. Delaware, USA IDEX Biometrics UK Ltd. United Kingdom IDEX Electronics (Shanghai) Co., Ltd. China

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista